A stunning 3,000 percent sales growth in the last three years. An IPO. Making Forbes’ list of “America’s Most Promising Companies.”
With those accolades, one could say that Lisa Earnhardt ’96 has had a pretty nice run since joining med-tech startup Intersect ENT as president and CEO.
Earnhardt sat down and spoke with Kellogg about her post-IPO plans for Intersect, new ways of inspiring her growing team and the challenges of driving focus to achieve impactful goals.